Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C22H32O2 |
| Molecular Weight | 328.4883 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 4 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)OC\C=C(C)\C=C\C=C(C)/C=C/C1=C(C)CCCC1(C)C
InChI
InChIKey=QGNJRVVDBSJHIZ-AQDFTDIISA-N
InChI=1S/C22H32O2/c1-17(9-7-10-18(2)14-16-24-20(4)23)12-13-21-19(3)11-8-15-22(21,5)6/h7,9-10,12-14H,8,11,15-16H2,1-6H3/b10-7+,13-12+,17-9-,18-14+
| Molecular Formula | C22H32O2 |
| Molecular Weight | 328.4883 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 4 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 01:26:16 UTC 2023
by
admin
on
Sat Dec 16 01:26:16 UTC 2023
|
| Record UNII |
2K3YP54BYU
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C804
Created by
admin on Sat Dec 16 01:26:16 UTC 2023 , Edited by admin on Sat Dec 16 01:26:16 UTC 2023
|
||
|
FDA ORPHAN DRUG |
324410
Created by
admin on Sat Dec 16 01:26:16 UTC 2023 , Edited by admin on Sat Dec 16 01:26:16 UTC 2023
|
||
|
FDA ORPHAN DRUG |
320410
Created by
admin on Sat Dec 16 01:26:16 UTC 2023 , Edited by admin on Sat Dec 16 01:26:16 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/11/861
Created by
admin on Sat Dec 16 01:26:16 UTC 2023 , Edited by admin on Sat Dec 16 01:26:16 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
EU/3/11/861(POSITIVE)
Created by
admin on Sat Dec 16 01:26:16 UTC 2023 , Edited by admin on Sat Dec 16 01:26:16 UTC 2023
|
PRIMARY | Treatment of Leber’s congenital amaurosis 13/05/2011 Positive | ||
|
29584-22-3
Created by
admin on Sat Dec 16 01:26:16 UTC 2023 , Edited by admin on Sat Dec 16 01:26:16 UTC 2023
|
PRIMARY | |||
|
C152967
Created by
admin on Sat Dec 16 01:26:16 UTC 2023 , Edited by admin on Sat Dec 16 01:26:16 UTC 2023
|
PRIMARY | |||
|
DB12112
Created by
admin on Sat Dec 16 01:26:16 UTC 2023 , Edited by admin on Sat Dec 16 01:26:16 UTC 2023
|
PRIMARY | |||
|
100000178277
Created by
admin on Sat Dec 16 01:26:16 UTC 2023 , Edited by admin on Sat Dec 16 01:26:16 UTC 2023
|
PRIMARY | |||
|
SUB193919
Created by
admin on Sat Dec 16 01:26:16 UTC 2023 , Edited by admin on Sat Dec 16 01:26:16 UTC 2023
|
PRIMARY | |||
|
9892
Created by
admin on Sat Dec 16 01:26:16 UTC 2023 , Edited by admin on Sat Dec 16 01:26:16 UTC 2023
|
PRIMARY | |||
|
EU/3/11/865(POSITIVE)
Created by
admin on Sat Dec 16 01:26:16 UTC 2023 , Edited by admin on Sat Dec 16 01:26:16 UTC 2023
|
PRIMARY | Treatment of retinitis pigmentosa 13/05/2011 Positive | ||
|
2K3YP54BYU
Created by
admin on Sat Dec 16 01:26:16 UTC 2023 , Edited by admin on Sat Dec 16 01:26:16 UTC 2023
|
PRIMARY | |||
|
10245972
Created by
admin on Sat Dec 16 01:26:16 UTC 2023 , Edited by admin on Sat Dec 16 01:26:16 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
METABOLITE ACTIVE -> PRODRUG |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|